Magnolia NeuroSciences Investors
Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.
Investors
%20.jpg)
Headquarters:
New York, New York, United States
Employee Number:
1-10
Founded Date:
2018
Number Of Exists:
N/A
Industry:
P4 Medicine
Investor Type:
Healthcare Company